Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023

BUY
$6.28 - $9.85 $1.91 Million - $2.99 Million
304,000 Added 400.0%
380,000 $3.08 Million
Q4 2022

Feb 14, 2023

SELL
$6.09 - $7.93 $354,438 - $461,526
-58,200 Reduced 43.37%
76,000 $477,000
Q1 2022

May 16, 2022

BUY
$21.6 - $27.79 $2.16 Million - $2.78 Million
100,000 Added 292.4%
134,200 $3.07 Million
Q2 2021

Aug 16, 2021

SELL
$27.43 - $32.7 $2.04 Million - $2.43 Million
-74,400 Reduced 68.51%
34,200 $1 Million
Q1 2021

May 17, 2021

BUY
$21.37 - $34.38 $1.74 Million - $2.8 Million
81,500 Added 300.74%
108,600 $3.45 Million
Q3 2020

Nov 16, 2020

SELL
$14.88 - $20.13 $1.79 Million - $2.42 Million
-120,300 Reduced 81.61%
27,100 $421,000
Q2 2020

Aug 14, 2020

SELL
$13.31 - $20.51 $966,306 - $1.49 Million
-72,600 Reduced 33.0%
147,400 $2.7 Million
Q1 2020

May 15, 2020

SELL
$12.98 - $30.25 $2.21 Million - $5.14 Million
-170,000 Reduced 43.59%
220,000 $3.41 Million
Q4 2019

Feb 14, 2020

BUY
$18.89 - $31.89 $1.32 Million - $2.23 Million
70,000 Added 21.88%
390,000 $11.7 Million
Q3 2019

Nov 14, 2019

BUY
$20.88 - $25.66 $3.55 Million - $4.36 Million
170,000 Added 113.33%
320,000 $6.99 Million
Q2 2019

Aug 14, 2019

SELL
$20.52 - $26.45 $9.43 Million - $12.2 Million
-459,500 Reduced 75.39%
150,000 $3.78 Million
Q1 2019

May 15, 2019

SELL
$20.23 - $26.29 $8.81 Million - $11.4 Million
-435,500 Reduced 41.67%
609,500 $15.1 Million
Q4 2018

Feb 14, 2019

SELL
$17.64 - $28.32 $1.23 Million - $1.98 Million
-70,000 Reduced 6.28%
1,045,000 $19.3 Million
Q3 2018

Nov 14, 2018

BUY
$20.64 - $25.67 $23 Million - $28.6 Million
1,115,000 New
1,115,000 $28.6 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.95B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.